Epidemiology of carbapenem-resistant Enterobacteriaceae in a Moroccan hospital from 2017 to 2022 | ||||
| Microbes and Infectious Diseases | ||||
| Articles in Press, Accepted Manuscript, Available Online from 19 May 2024 | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/mid.2024.283679.1907 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
El mehdi Belouad  1, 2; Elmostafa Benaissa1, 2; Nadia El mrimar1; Yassine Eddair1; Adil Maleb3; Mostafa Elouennass1, 2
| ||||
| 1Research Team of Epidemiology and Bacterial Resistance, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco | ||||
| 2Department of Clinical Bacteriology, Mohammed V Military Teaching Hospital, Rabat, Morocco | ||||
| 3Laboratory of Microbiology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, University Mohammed the First, Oujda, Morocco | ||||
| Abstract | ||||
| Background: Carbapenem-resistant Enterobacteriaceae is a growing global health concern, contributing to millions of deaths annually. The widespread use of carbapenems has led to the emergence of carbapenem-resistant organisms, posing significant challenges in healthcare settings worldwide. Our study aimed to determine the prevalence and progression of carbapenem-resistant Enterobacteriaceae in Moroccan hospital. Methods: We conducted a retrospective study over a six-year period (2017-2022) at the Mohammed V Military Hospital in Morocco. Enterobacteriaceae isolates from various clinical specimens were identified using standard microbiological methods. Antimicrobial susceptibility testing, employing a range of antibiotics recommended by the committee on Antimicrobial Susceptibility Testing of the French Society for Microbiology (CASFM). The production of Extended Spectrum Beta-Lactamases (ESBL) was evaluated using the double disk synergy test. Results: Out of the 20921 Enterobacteriaceae, carbapenems resistance was observed in 9%. The majority of CRE instances were attributed to K. pneumoniae (47.1%), followed by E. cloacae (22.5%) and E. coli (17.6%). The most frequently encountered types of specimens were urine (59.8%) and wound (15.3%), while blood accounted for only 8.5% of CRE isolates. The CRE isolates demonstrated multi-drug resistance, showing resistance to a majority of antibiotics, notably Ciprofloxacin (78%), Trimethoprim/sulfamethoxazole (69%), and Gentamicin (63%). Among all CRE isolates, 32.5% were expressing the ESBL phenotype. Conclusion: This study underscores the urgent need for surveillance and intervention strategies to curb the escalating rates of carbapenem-resistant Enterobacteriaceae. The findings provide valuable insights into the resistance landscape, informing clinical approaches and guiding future research aimed at combating this critical threat to global health. | ||||
| Keywords | ||||
| Carbapenem-resistant; Enterobacteriaceae; CRE; Epidemiology; Antimicrobial resistance | ||||
|
Statistics Article View: 31 |
||||
